Dr. Larry Einhorn, Indiana University, expresses his concerns about the cost of developing cancer drugs and the challenge of paying for extremely expensive cancer treatments that are given in anticipation of modest clinical benefits.
Podcast: Play in new window
| Download (Duration: 2:29 — 28.6MB)
You must be logged in to post a comment.
Mission | Disclaimer